BeStock  
Stocks › Biotechnology › ROIV

Roivant Sciences ROIV

US equityMarket cap rank #706Biotechnology
$38.66 −$0.31 (-0.78%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $38.68 +0.06%
Open$38.86
Prev close$38.96
Day range$38.46 – $39.51
Volume3.97M
Market cap$28.01B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-66.6x
CheapRich

Near the bottom of its 5-year range · 6th percentile, 5-year average -18.3x

Price / book7.0x
CheapRich

Near the top of its 5-year range · 84th percentile, 5-year average 3.8x

#4801 of 5338 stocks by PB (1 = cheapest)

Price / sales681.8x
CheapRich

Above its usual level · 79th percentile, 5-year average 514.3x

#5087 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-95x-59x-22x14xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$36.46
Price vs. fair value+6.0%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.97 – 3.81 84% (pricier than usual) #4801 of 5338 (1 = cheapest)
PE -66.65 -33.76 -18.27 6% (cheaper than usual) –
PS 681.76 74.21 514.34 79% (pricier than usual) #5087 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ROIV.

Sign in to join the discussion.

Scroll to Top